Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Foteini, Vasilopoulou"'
Autor:
Foteini Vasilopoulou, Aina Bellver-Sanchis, Júlia Companys-Alemany, Júlia Jarne-Ferrer, Alba Irisarri, Verónica Palomera-Ávalos, Celia Gonzalez-Castillo, Daniel Ortuño-Sahagún, Coral Sanfeliu, Mercè Pallàs, Christian Griñán-Ferré
Publikováno v:
Cells, Vol 11, Iss 16, p 2603 (2022)
Behavioural and psychological symptoms of dementia (BPSD) are presented in 95% of Alzheimer’s Disease (AD) patients and are also associated with neurotrophin deficits. The molecular mechanisms leading to age-related diseases are still unclear; howe
Externí odkaz:
https://doaj.org/article/02d125678df247839703b3369815d9ee
Autor:
Foteini Vasilopoulou, Andrea Bagan, Sergio Rodriguez-Arevalo, Carmen Escolano, Christian Griñán-Ferré, Mercè Pallàs
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 475 (2020)
Behavioural and psychological symptoms of dementia (BPSD), including fear-anxiety- and depressive-like behaviour, are present in Alzheimer’s disease (AD), together with memory decline. I2-imidazoline receptors (I2-IRs) have been associated with neu
Externí odkaz:
https://doaj.org/article/b50f4266318b4b06bdd668b207879a8e
Autor:
Carmen Escolano, Andrea Bagán, Christian Griñán-Ferré, Sònia Abás, Mercè Pallàs, Sergio Rodríguez-Arévalo, Foteini Vasilopoulou
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
GeroScience
Universidad de Barcelona
GeroScience
Brain aging and dementia are current problems that must be solved. The levels of imidazoline 2 receptors (I(2)-IRs) are increased in the brain in Alzheimer’s disease (AD) and other neurodegenerative diseases. We tested the action of the specific an
Publikováno v:
Genes, Vol 12, Iss 1315, p 1315 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
Genes
Volume 12
Issue 9
Dipòsit Digital de la UB
Universidad de Barcelona
Genes
Volume 12
Issue 9
I2-IR have been found dysregulated in patients with neurodegenerative diseases, such as Alzheimer’s disease (AD), in which the importance of neuroinflammation in the establishment and maintenance of cognitive decline is well-documented. To research
Autor:
Foteini, Vasilopoulou, Sergio, Rodríguez-Arévalo, Andrea, Bagán, Carmen, Escolano, Christian, Griñán-Ferré, Mercè, Pallàs
Publikováno v:
British journal of pharmacologyREFERENCES. 178(15)
The development of effective therapeutic strategies against Alzheimer's disease (AD) remains a challenge. I5XFAD female mice were treated with low doses (1 mg·kgChronic low-dose treatment with LSL60101 and donepezil reversed cognitive deficits and i
Autor:
Sergio, Rodriguez-Arévalo, Andrea, Bagán, Christian, Griñán-Ferré, Foteini, Vasilopoulou, Mercè, Pallàs, Iria, Brocos-Mosquera, Luis F, Callado, M Isabel, Loza, Antón L, Martínez, José, Brea, Belén, Pérez, Elies, Molins, Steven, De Jonghe, Dirk, Daelemans, Milica, Radan, Teodora, Djikic, Katarina, Nikolic, Elena, Hernández-Hernández, M Julia, García-Fuster, Jesús A, García-Sevilla, Carmen, Escolano
Publikováno v:
European journal of medicinal chemistry. 222
Recent findings unveil the pharmacological modulation of imidazoline I
Autor:
A.M. Canudas, Daniel Ortuño-Sahagún, Verónica Palomera-Ávalos, Christian Griñán-Ferré, Foteini Vasilopoulou, Mercè Pallàs, Júlia Companys-Alemany
Alzheimer’s disease (AD) is characterized by cognitive impairment and different non-cognitive deficits called “Behavioural and psychological symptoms of dementia” (BPSD) related to neurotrophin alterations, which differ from those presented in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f834bf74ea6b29f5c13203e8aa7f6d85
https://doi.org/10.20944/preprints202101.0162.v1
https://doi.org/10.20944/preprints202101.0162.v1
Autor:
Christian Griñán-Ferré, Carmen Escolano, Mercè Pallàs, Andrea Bagán, Foteini Vasilopoulou, Sergio Rodríguez-Arévalo
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Background and Purpose: The development of effective therapeutic strategies against Alzheimer's disease (AD) remains a challenge. I2 Imidazoline receptors (I2-IR) ligands have a neuroprotective role in AD. Moreover, co-treatment of acetylcholinestera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd33e2401e431b22f923cedcb7a2e8c7
http://hdl.handle.net/2445/178766
http://hdl.handle.net/2445/178766
Autor:
Mercè Pallàs, Andrea Bagán, Carmen Escolano, Sergio Rodríguez-Arévalo, Christian Griñán-Ferré, Foteini Vasilopoulou
Publikováno v:
Pharmaceutics
Volume 12
Issue 5
Pharmaceutics, Vol 12, Iss 475, p 475 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Volume 12
Issue 5
Pharmaceutics, Vol 12, Iss 475, p 475 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Behavioural and psychological symptoms of dementia (BPSD), including fear-anxiety- and depressive-like behaviour, are present in Alzheimer&rsquo
s disease (AD), together with memory decline. I2-imidazoline receptors (I2-IRs) have been associated
s disease (AD), together with memory decline. I2-imidazoline receptors (I2-IRs) have been associated
Autor:
Sònia, Abás, Sergio, Rodríguez-Arévalo, Andrea, Bagán, Christian, Griñán-Ferré, Foteini, Vasilopoulou, Iria, Brocos-Mosquera, Carolina, Muguruza, Belén, Pérez, Elies, Molins, F Javier, Luque, Pilar, Pérez-Lozano, Steven, de Jonghe, Dirk, Daelemans, Lieve, Naesens, José, Brea, M Isabel, Loza, Elena, Hernández-Hernández, Jesús A, García-Sevilla, M Julia, García-Fuster, Milica, Radan, Teodora, Djikic, Katarina, Nikolic, Mercè, Pallàs, Luis F, Callado, Carmen, Escolano
Publikováno v:
Journal of medicinal chemistry. 63(7)
Imidazoline I